Andrew Slade

728 total citations
17 papers, 578 citations indexed

About

Andrew Slade is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Andrew Slade has authored 17 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Virology. Recurrent topics in Andrew Slade's work include Virus-based gene therapy research (7 papers), HIV Research and Treatment (5 papers) and CRISPR and Genetic Engineering (3 papers). Andrew Slade is often cited by papers focused on Virus-based gene therapy research (7 papers), HIV Research and Treatment (5 papers) and CRISPR and Genetic Engineering (3 papers). Andrew Slade collaborates with scholars based in United Kingdom, Canada and Spain. Andrew Slade's co-authors include Peter C. Terry, Caroline J. Richardson, Michael A. Batey, Niall M.B. Martin, David R. Newell, Nicola J. Curtin, Yan Zhao, Alan Lau, Suzanne Kyle and Neil Almond and has published in prestigious journals such as Nature Biotechnology, Cancer Research and Biochemical Journal.

In The Last Decade

Andrew Slade

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Slade United Kingdom 10 357 191 136 62 53 17 578
Page Bouchard United States 14 438 1.2× 283 1.5× 86 0.6× 7 0.1× 29 0.5× 22 1.1k
Lu Qin United States 9 247 0.7× 217 1.1× 191 1.4× 61 1.0× 22 0.4× 30 591
Pavel Shiyanov United States 11 529 1.5× 239 1.3× 74 0.5× 15 0.2× 31 0.6× 17 698
Prashanth Ak United States 7 436 1.2× 188 1.0× 81 0.6× 17 0.3× 40 0.8× 9 596
Pablo Gluschankof France 12 287 0.8× 103 0.5× 29 0.2× 137 2.2× 22 0.4× 20 537
Mary Mathieu United States 11 485 1.4× 170 0.9× 17 0.1× 36 0.6× 35 0.7× 20 953
Mary E. Englert United States 15 150 0.4× 88 0.5× 41 0.3× 29 0.5× 60 1.1× 26 555
Yoko Ogata Japan 13 248 0.7× 142 0.7× 24 0.2× 109 1.8× 24 0.5× 20 543
Alan Bennett United States 12 277 0.8× 563 2.9× 145 1.1× 15 0.2× 19 0.4× 39 880
Kenneth K Lee United States 13 1.5k 4.1× 198 1.0× 110 0.8× 15 0.2× 6 0.1× 25 1.8k

Countries citing papers authored by Andrew Slade

Since Specialization
Citations

This map shows the geographic impact of Andrew Slade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Slade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Slade more than expected).

Fields of papers citing papers by Andrew Slade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Slade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Slade. The network helps show where Andrew Slade may publish in the future.

Co-authorship network of co-authors of Andrew Slade

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Slade. A scholar is included among the top collaborators of Andrew Slade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Slade. Andrew Slade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Smith, Julia Perkins, Georg A. Holländer, Paul Predki, et al.. (2016). Emerging platform bioprocesses for viral vectors and gene therapies. Oxford University Research Archive (ORA) (University of Oxford). 14. 1 indexed citations
2.
Batey, Michael A., Yan Zhao, Suzanne Kyle, et al.. (2013). Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer. Molecular Cancer Therapeutics. 12(6). 959–967. 113 indexed citations
3.
Munck, Joanne M., Michael A. Batey, Yan Zhao, et al.. (2012). Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K. Molecular Cancer Therapeutics. 11(8). 1789–1798. 99 indexed citations
4.
Hingorani, Mohan, Christine L. White, Martin Gore, et al.. (2008). Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors. Cancer Research. 68(23). 9771–9778. 20 indexed citations
5.
Braybrooke, Jeremy, Andrew Slade, G. Deplanque, et al.. (2005). Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma. Clinical Cancer Research. 11(4). 1512–1520. 74 indexed citations
6.
Al‐Rubeai, Mohamed, J. Warnock, Toby Price, & Andrew Slade. (2004). Use of a Fluidized-Bed Bioreactor for the Production of Retroviral Vectors for Gene Therapy Applications. BioProcessing Journal. 3(5). 41–45. 4 indexed citations
7.
Kan, O., Leigh G. Griffiths, Dilair Baban, et al.. (2001). Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer. Cancer Gene Therapy. 8(7). 473–482. 40 indexed citations
8.
Baban, Dilair, et al.. (2000). Brief Report: Analysis of 4070A Envelope Levels in Retroviral Preparations and Effect on Target Cell Transduction Efficiency. Human Gene Therapy. 11(10). 1439–1451. 28 indexed citations
9.
Kan, O., Leigh G. Griffiths, Sharifah Iqball, et al.. (1999). Preclinical Evaluation of Human Cytochrome P450 2b6 (Cyp2b6) as a Therapeutic Gene Delivered by a Retroviral Vehicle for Gene-Directed Enzyme Prodrug Therapy (GDEPT) of Cancer. Nature Biotechnology. 17(S4). 37–37. 1 indexed citations
10.
Slade, Andrew, et al.. (1997). Transmission of equine herpesvirus 2 to the mouse: characterization of a new laboratory infection model.. Journal of General Virology. 78(5). 1119–1124. 6 indexed citations
11.
Ranjbar, Shahin, Andrew Slade, Adrian Jenkins, et al.. (1995). Molecular Characterization of an HIV Type 1 Isolate from Burundi. AIDS Research and Human Retroviruses. 11(8). 981–984. 5 indexed citations
12.
Slade, Andrew, Adrian Jenkins, Janet S. Bootman, et al.. (1995). Similar Patterns of Simian Immunodeficiency Virus env Sequences Are Found in the Blood and Lymphoid Tissues of Chronically Infected Macaques. AIDS Research and Human Retroviruses. 11(12). 1509–1516. 5 indexed citations
13.
Terry, Peter C. & Andrew Slade. (1995). Discriminant Effectiveness of Psychological State Measures in Predicting Performance Outcome in Karate Competition. Perceptual and Motor Skills. 81(1). 275–286. 77 indexed citations
14.
Slade, Andrew, et al.. (1993). Simian Immunodeficiency Virus (mac 251-32H) Transmembrane Protein Sequence Remains Conserved Throughout the Course of Infection in Macaques. AIDS Research and Human Retroviruses. 9(2). 133–139. 7 indexed citations
15.
Almond, Neil, et al.. (1992). Population Sequence Analysis of a Simian Immunodeficiency Virus (32H Reisolate of SIV mac251 ): A Virus Stock Used for International Vaccine Studies. AIDS Research and Human Retroviruses. 8(1). 77–88. 47 indexed citations
16.
Slade, Andrew, et al.. (1991). Site‐directed chemical conversion of serine to cysteine in penicillin acylase from Escherichia coli ATCC 11105. European Journal of Biochemistry. 197(1). 75–80. 32 indexed citations
17.
Martín, Julio, et al.. (1991). Chemical modification of serine at the active site of penicillin acylase from Kluyvera citrophila. Biochemical Journal. 280(3). 659–662. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Page Bouchard Breakdown of academic impact, for papers by Lu Qin Breakdown of academic impact, for papers by Pavel Shiyanov Breakdown of academic impact, for papers by Prashanth Ak Breakdown of academic impact, for papers by Pablo Gluschankof Breakdown of academic impact, for papers by Mary Mathieu Breakdown of academic impact, for papers by Mary E. Englert Breakdown of academic impact, for papers by Yoko Ogata Breakdown of academic impact, for papers by Alan Bennett Breakdown of academic impact, for papers by Kenneth K Lee
Rankless by CCL
2026